- ArQule (NASDAQ:ARQL) initiated with Buy rating and $13 (63% upside) price target at H.C. Wainwright.
- More news on: ArQule, Inc., Esperion Therapeutics, Inc., Aurora Cannabis Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Tuesday's announcement that the DEA is moving towards rescheduling cannabis from Schedule I to Schedule III, has already injecte...
Cannabis stocks Canopy Growth Corporation (NASDAQ:CGC), Aurora Cannabis, Inc. (NASDAQ:ACB) and Tilray Brands, Inc. (NASDAQ:TLRY) shares are trading...
A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $12.22 on volume of 208,602,591 shares CytomX Therapeutics Inc. (CTMX) rose 214.7% to $5.13 on volume of 203,288,355 shares Akanda Corp. (AKAN) rose 25.4% to $0.1166 on volume of 179,349,234 shares ...